[go: up one dir, main page]

TR199801835A2 - Antimikrobiyal kompozisyonlar. - Google Patents

Antimikrobiyal kompozisyonlar.

Info

Publication number
TR199801835A2
TR199801835A2 TR1998/01835A TR9801835A TR199801835A2 TR 199801835 A2 TR199801835 A2 TR 199801835A2 TR 1998/01835 A TR1998/01835 A TR 1998/01835A TR 9801835 A TR9801835 A TR 9801835A TR 199801835 A2 TR199801835 A2 TR 199801835A2
Authority
TR
Turkey
Prior art keywords
antimicrobial compositions
compositions containing
formula
kefalosporin
pyrrolidinone
Prior art date
Application number
TR1998/01835A
Other languages
English (en)
Other versions
TR199801835A3 (tr
Inventor
Angehrn Peter
Heinze-Krauss Ingrid
Page Malcolm
G.F. Richter Hans
Original Assignee
F. Hoffmann -La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann -La Roche Ag filed Critical F. Hoffmann -La Roche Ag
Publication of TR199801835A2 publication Critical patent/TR199801835A2/tr
Publication of TR199801835A3 publication Critical patent/TR199801835A3/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

(Formül).Bulus, yukaridaki formül I'in vinil-pirrolidinon kefalosporin türevlerinin karbapenem antibiyotikleri ile ya da -laktamaz inhibitörleri ile bir kombinasyonunu içeren antimikrobiyal kompozisyonlar ile, kombinasyonlari içeren farmasötik kompozisyonlar ve kompozisyonlarin MRSA enfeksiyonlarini içeren enfeksiyon hastaliklarinin tedavisi ya da profilaksisi için bir ilaç üretmek üzere kullanimi ile ilgilidir.
TR1998/01835A 1997-09-15 1998-09-15 Antimikrobiyal kompozisyonlar. TR199801835A3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97115997 1997-09-15

Publications (2)

Publication Number Publication Date
TR199801835A2 true TR199801835A2 (tr) 1999-04-21
TR199801835A3 TR199801835A3 (tr) 1999-04-21

Family

ID=8227350

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01835A TR199801835A3 (tr) 1997-09-15 1998-09-15 Antimikrobiyal kompozisyonlar.

Country Status (16)

Country Link
US (1) US6150350A (tr)
EP (1) EP0911030B1 (tr)
JP (1) JP4621311B2 (tr)
KR (1) KR100630012B1 (tr)
CN (1) CN1186021C (tr)
AR (1) AR013490A1 (tr)
AT (1) ATE292994T1 (tr)
AU (1) AU747285B2 (tr)
BR (1) BR9803443A (tr)
CA (1) CA2247232C (tr)
DE (1) DE69829720T2 (tr)
DK (1) DK0911030T3 (tr)
ES (1) ES2241084T3 (tr)
PT (1) PT911030E (tr)
TR (1) TR199801835A3 (tr)
ZA (1) ZA988399B (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0102350A2 (hu) * 1998-06-22 2001-11-28 F.Hoffmann-La Roche Ag. Propenil-cefalosporin-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
AU1654900A (en) * 1998-12-03 2000-06-19 F. Hoffmann-La Roche Ag Bi-pyrrolidinylvinl (carba) cephalosporins
JP4583559B2 (ja) * 2000-07-24 2010-11-17 栄研化学株式会社 Ｍｒｓａスクリーニング用培地
CN100384857C (zh) * 2003-11-28 2008-04-30 浙江永宁制药厂 耐β-内酰胺酶的头孢菌素酯化合物及其盐
CN112608369A (zh) * 2020-12-30 2021-04-06 中国海洋大学 一种具有抑菌活性的细菌素及其生产方法及用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69019395D1 (de) * 1989-02-21 1995-06-22 Banyu Pharma Co Ltd Zusammensetzung gegen Mikroben.
JPH0347122A (ja) * 1989-02-21 1991-02-28 Banyu Pharmaceut Co Ltd 抗菌性組成物
GB9019743D0 (en) * 1990-09-10 1990-10-24 Beecham Group Plc Novel compounds
EP0620225B1 (en) * 1993-04-16 2002-11-13 Basilea Pharmaceutica AG Cephalosporin derivatives
KR100214288B1 (ko) * 1993-04-16 1999-08-02 성재갑 안개서림 방지용 내마모성 피복조성물 및 이를 도포한 합성수지 성형품
TW383308B (en) * 1993-08-24 2000-03-01 Hoffmann La Roche 2-beta-alkenyl penam sulfones as beta-lactamase inhibitors
US5464616A (en) * 1994-08-04 1995-11-07 Synphar Laboratories, Ind. 6β-substituted penicillanic acids as beta-lactamase inhibitors
CN1176641A (zh) * 1995-02-27 1998-03-18 弗·哈夫曼-拉罗切有限公司 3－吡咯烷亚基－2－酮－头孢菌素衍生物
EP0841339B1 (en) * 1996-11-06 2007-02-21 Basilea Pharmaceutica AG Vinylpyrrolidinon cephalosporin derivatives

Also Published As

Publication number Publication date
EP0911030A3 (en) 1999-10-13
PT911030E (pt) 2005-08-31
DE69829720D1 (de) 2005-05-19
CA2247232C (en) 2007-08-28
US6150350A (en) 2000-11-21
AU747285B2 (en) 2002-05-16
ATE292994T1 (de) 2005-04-15
EP0911030A2 (en) 1999-04-28
AR013490A1 (es) 2000-12-27
CA2247232A1 (en) 1999-03-15
CN1216246A (zh) 1999-05-12
ZA988399B (en) 1999-03-15
ES2241084T3 (es) 2005-10-16
DE69829720T2 (de) 2006-03-09
AU8425198A (en) 1999-04-01
BR9803443A (pt) 2000-02-08
CN1186021C (zh) 2005-01-26
EP0911030B1 (en) 2005-04-13
KR100630012B1 (ko) 2006-11-30
JPH11140087A (ja) 1999-05-25
JP4621311B2 (ja) 2011-01-26
KR19990029769A (ko) 1999-04-26
DK0911030T3 (da) 2005-08-01
TR199801835A3 (tr) 1999-04-21

Similar Documents

Publication Publication Date Title
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
TR199901127T2 (tr) Antibakteriyel etkili 6-O-ikameli ketolitler.
ZA9711607B (en) Novel cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
TR199903191T2 (tr) Vorikonazol içeren ilaç formülasyonlari.
AUPR213700A0 (en) Antiviral agents
SE0102315D0 (sv) Compounds
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
BR1100987A (pt) Composto, composição farmacêutica da matéria, e, composição veterinária
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
DK1057828T3 (da) Orale trovafloxacin-suspensioner
BR0309757A (pt) 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases
DK0866791T3 (da) Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler
DE69613975D1 (de) Dialkyltiacumicine
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
DE69600244D1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
TR199801835A2 (tr) Antimikrobiyal kompozisyonlar.